Russian tax service to tighten control of foreign pharma firms on domestic market

Global drugmakers operating in Russia will be obliged to transfer information on the price of their drugs to a single information system operated by the Russian Federal Tax Service, as part of the new state strategy for drugs’ labeling in the Russian pharmaceutical market, reports The Pharma Letter’s local correspondent.

In the meantime, according to producers, the transfer of the data will be associated with additional costs and bureaucratic hurdles for them, while any malfunctions of the system and delays in the transfer of the needed information may lead to suspicions by the Russian Federal Tax Service of underpaying taxes by the companies.

Currently foreign drugmakers operating in Russia are waiting for explanations from the Russian Federal Tax Service regarding with the new practice and its details.